ALLMedicine™ Lipid Disorders Center
Research & Reviews 303 results
https://doi.org/10.3390/ijerph19127289
International Journal of Environmental Research and Publi... Dąbek J, Piotrkowicz J et. al.
Jun 25th, 2022 - Cardiovascular diseases are the most common causes of death, in both Poland and the world. Their development and progression are largely influenced by the lifestyle with the presence/occurrence of classic, modifiable risk factors. Among them, low ...
https://clinicaltrials.gov/ct2/show/NCT02311335
Jun 24th, 2022 - The primary purpose of this discovery protocol is to identify new lipid genes from subjects with rare genetic lipids disorders. We will take advantage of the new technology of whole exome sequencing to find the cause of dyslipidemia that we haven ...
https://doi.org/10.1016/j.jacc.2022.04.015
Journal of the American College of Cardiology; Rallidis LS, Xenogiannis I et. al.
Jun 17th, 2022 - Among patients presenting with acute myocardial infarction (AMI), the proportion of young individuals has increased in recent years. Although coronary atherosclerosis is less extensive in young patients with AMI, with higher prevalence of single-v...
https://clinicaltrials.gov/ct2/show/NCT05321095
May 5th, 2022 - Early detection and appropriate treatment of kidney disease is important as this may prevent future cardiovascular complications and end-organ damage more effectively than intervention in more advanced stages of disease. There is a well-establishe...
https://doi.org/10.1016/j.jaad.2021.06.902
Journal of the American Academy of Dermatology; Karch J, Raja A et. al.
May 4th, 2022 - In this Part 1 of a 2-part continuing medical education series, we review the epidemiology and pathophysiology of cardiovascular disease, its association with cutaneous symptoms, and the diagnosis and evaluation of cutaneous features of cardiovasc...
Guidelines 3 results
https://www.ncbi.nlm.nih.gov/pubmed/28075093
American Family Physician;
Jan 12th, 2017 - Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.|2017||therapeutic use,diagnosis,therapy,diagnosis,drug therapy,
https://doi.org/10.1001/jama.2016.15450
JAMA , Bibbins-Domingo K et. al.
Nov 14th, 2016 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid...
https://doi.org/10.1001/jama.2016.9852
JAMA , Bibbins-Domingo K et. al.
Aug 18th, 2016 - Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovas...
Drugs 1 results see all →
Clinicaltrials.gov 23 results
https://clinicaltrials.gov/ct2/show/NCT02311335
Jun 24th, 2022 - The primary purpose of this discovery protocol is to identify new lipid genes from subjects with rare genetic lipids disorders. We will take advantage of the new technology of whole exome sequencing to find the cause of dyslipidemia that we haven ...
https://clinicaltrials.gov/ct2/show/NCT05321095
May 5th, 2022 - Early detection and appropriate treatment of kidney disease is important as this may prevent future cardiovascular complications and end-organ damage more effectively than intervention in more advanced stages of disease. There is a well-establishe...
https://clinicaltrials.gov/ct2/show/NCT04009356
Mar 9th, 2022 - This study is proposed to all obese patients evaluated for potential bariatric surgery during a multidisciplinary evaluation for about 1 year following current french national recommendations. Demographics are collected from medical records (age, ...
https://clinicaltrials.gov/ct2/show/NCT05214872
Jan 31st, 2022 - Chronic Kidney Disease has a significant impact on the cardiovascular system. From many different complications of CKD, one to mention is arterial stiffness. This disorder results from many pathologies, including inflammation, arterial hypertensio...
https://clinicaltrials.gov/ct2/show/NCT05158231
Dec 15th, 2021 - Cardiovascular diseases, particularly coronary artery disease (CAD), is considered as a main cause of death and disability in the developed countries as its responsible for about 1 in every 5 deaths In the last few years. Acute coronary syndrome (...
News 66 results
https://www.medscape.com/viewarticle/974013
May 13th, 2022 - The "Twincretin" era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration's (FDA's) approval of tirzepatide for this indication on May 13, making it the first approved agent that works as a dual agonist fo...
https://www.medscape.com/viewarticle/966683
Feb 2nd, 2022 - This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the University of Duisburg-Essen in Germany. This month I'm deviating from what I usually do, which is reporting a handful of recent studies that may impact yo...
https://www.medscape.com/viewarticle/945285
Feb 10th, 2021 - People with diabetes pose a particular challenge when trying to assess cognitive function longitudinally. Population data suggest that the risk of developing dementia, both vascular and neurodegenerative, among people with diabetes followed for 20...
https://www.medscape.com/viewarticle/939982
Oct 29th, 2020 - Dr Yehuda Handelsman A new algorithm on lipid management and prevention of cardiovascular disease from the American Association of Clinical Endocrinologists* (AACE) and the American College of Endocrinology (ACE) is "a nice cookbook" that many cli...
https://www.medscape.com/viewarticle/932275
Jun 13th, 2020 - Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the Food and Drug Administration announced June 11. "Long-acting insulin products li...